DEKK-TEC, INC.
- Country
- ๐บ๐ธUnited States
- Ownership
- Private
- Established
- 1983-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.dekk-tec.com
DM-CHOC-PEN for Brain Tumors in AYA Subjects
- First Posted Date
- 2018-09-13
- Last Posted Date
- 2022-11-08
- Lead Sponsor
- DEKK-TEC, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT03668847
- Locations
- ๐บ๐ธ
Tulane University Medical Center, New Orleans, Louisiana, United States
DM-CHOC-PEN Plus Radiation for Brain Tumors
- Conditions
- Advanced Cancer
- Interventions
- First Posted Date
- 2017-12-13
- Last Posted Date
- 2022-11-04
- Lead Sponsor
- DEKK-TEC, Inc.
- Target Recruit Count
- 19
- Registration Number
- NCT03371004
- Locations
- ๐บ๐ธ
Tulane University Medical Center, New Orleans, Louisiana, United States
๐บ๐ธTulane University Medical School, New Orleans, Louisiana, United States
๐บ๐ธDetroit Clinical Research Centers, Detroit, Michigan, United States
A Phase I Trial of DM-CHOC-PEN in Adolescent and Young Adult (AYA) Subjects With Advanced Cancers
- Conditions
- Advanced Cancer
- First Posted Date
- 2016-09-05
- Last Posted Date
- 2020-08-18
- Lead Sponsor
- DEKK-TEC, Inc.
- Registration Number
- NCT02889445
- Locations
- ๐บ๐ธ
Detroit Clinical Research Centers, Detroit, Michigan, United States
Study of 4-Demethyl-4-cholesteryloxycarbonylpenclome (DM-CHOC-PEN) in Patients With Brain Tumors
- Conditions
- Primary Brain TumorsMetastatic Malignant Neoplasm to Brain
- Interventions
- Drug: 4-Demethyl-4-cholestryloxycarbonylpenclomedine
- First Posted Date
- 2014-01-16
- Last Posted Date
- 2020-09-16
- Lead Sponsor
- DEKK-TEC, Inc.
- Target Recruit Count
- 29
- Registration Number
- NCT02038218
- Locations
- ๐บ๐ธ
Tulane University Medical Center, New Orleans, Louisiana, United States
๐บ๐ธDetroit Clinical Research Centers, Lansing, Michigan, United States
๐บ๐ธThe University of Texas Health Science Center, Houston, Texas, United States
Study of 4-Demethylcholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) in Patients With Advanced Cancer"
- First Posted Date
- 2013-11-06
- Last Posted Date
- 2020-08-04
- Lead Sponsor
- DEKK-TEC, Inc.
- Target Recruit Count
- 23
- Registration Number
- NCT01976910
- Locations
- ๐บ๐ธ
Tulane University Medical School, New Orleans, Louisiana, United States
Study of 4-Demethylcholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) in Patients With Advanced Cancer
- First Posted Date
- 2010-01-13
- Last Posted Date
- 2020-08-04
- Lead Sponsor
- DEKK-TEC, Inc.
- Target Recruit Count
- 22
- Registration Number
- NCT01048008
- Locations
- ๐บ๐ธ
Tulane University Medical School, New Orleans, Louisiana, United States
Topical Use of 4,4'-Dihydroxybenzophenone-2,4-Dinitrophenylhydrazone (A-007) in the Treatment of Advanced Malignancies Including Kaposi's Sarcoma and Lymphoproliferative Disorders
- Conditions
- Sarcoma, KaposiHIV InfectionsLymphoproliferative Disorders
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- DEKK-TEC, Inc.
- Target Recruit Count
- 25
- Registration Number
- NCT00002153
- Locations
- ๐บ๐ธ
DEKK - TEC Inc, New Orleans, Louisiana, United States